Anne De Monte

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

Journal: Open forum infectious diseases

Published: March 27, 2026

Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

Journal: The Journal of antimicrobial chemotherapy

Published: January 12, 2026

The DePASS initiative in healthcare access units: Do not miss the opportunity to detect HIV, HBV, and HCV.

The DePASS initiative in healthcare access units: Do not miss the opportunity to detect HIV, HBV, and HCV.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: October 24, 2025

No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people with HIV.

No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people with HIV.

Journal: AIDS (London, England)

Published: April 16, 2025

To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?

To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?

Journal: Open forum infectious diseases

Published: April 04, 2025

Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.

Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.

Journal: The Journal of antimicrobial chemotherapy

Published: October 14, 2024

DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.

DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.

Journal: The Journal of antimicrobial chemotherapy

Published: March 01, 2024

Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.

Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 30, 2022

Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up.

Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up.

Journal: Viruses

Published: March 15, 2022

Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?

Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?

Journal: Frontiers in medicine

Published: May 21, 2021

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

Journal: The Journal of antimicrobial chemotherapy

Published: February 25, 2021

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

Journal: The Journal of antimicrobial chemotherapy

Published: May 27, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026